Literature DB >> 24629813

Primary sclerosing cholangitis in patient with celiac disease complicated by cholecystic empyema and acute pancreatitis.

P Piccolboni, E Ragone, A Inzirillo, R Utili.   

Abstract

BACKGROUND: The association of celiac disease and sclerosing cholangitis is a well known, although unusual, pathologic feature of autoimmunity.
METHODS: A 64 year old patient presenting with sub-acute cholangitis and pancreatitis, treated with cholecystectomy and endoscopic sphincterotomy. The post-operative course, complicated by cholestatic jaundice, and subsequent clinical complications are described, showing how the diagnosis of sclerosing cholangitis was outlined after the Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and confirmed by liver biopsy. Long term treatment with Ursodeoxycholic acid has gradually normalized bilirubin values, while cholestasis enzymes are gradually decreasing. After 18 months bleeding from oesophageal varices ensued, which was controlled through endoscopic ligation.
CONCLUSIONS: The diagnosis of primary sclerosing cholangitis should be taken into account when cholangitis is associated with other immunity derangements and segmentary dilatations of the intra-hepatic bile ducts, but no dilatation of the main bile duct is noticed at imaging or endoscopy. Recovery of hepatic function should be always attempted before bringing the patient to surgery, in order to avoid postoperative hepatic decompensation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24629813      PMCID: PMC3926481     

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  15 in total

Review 1.  Management of primary sclerosing cholangitis.

Authors:  E Björnsson
Journal:  Minerva Gastroenterol Dietol       Date:  2009-06

2.  Immune-mediated diseases in primary sclerosing cholangitis.

Authors:  Laetitia E Lamberts; Marcel Janse; Elizabeth B Haagsma; Arie P van den Berg; Rinse K Weersma
Journal:  Dig Liver Dis       Date:  2011-06-22       Impact factor: 4.088

3.  [Primary sclerosing cholangitis: diagnosis, prognosis and treatment].

Authors:  Albert Parés
Journal:  Gastroenterol Hepatol       Date:  2010-12-03       Impact factor: 2.102

4.  Primary sclerosing cholangitis and celiac disease. A novel association.

Authors:  J E Hay; R H Wiesner; R G Shorter; N F LaRusso; W P Baldus
Journal:  Ann Intern Med       Date:  1988-11-01       Impact factor: 25.391

5.  Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis.

Authors:  Peter P Stanich; Einar Björnsson; Andrea A Gossard; Felicity Enders; Roberta Jorgensen; Keith D Lindor
Journal:  Dig Liver Dis       Date:  2011-01-19       Impact factor: 4.088

Review 6.  Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association.

Authors:  A Lawson; J West; G P Aithal; R F A Logan
Journal:  Aliment Pharmacol Ther       Date:  2005-02-15       Impact factor: 8.171

Review 7.  Pathogenesis and clinical significance of liver injury in celiac disease.

Authors:  Umberto Volta
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

8.  High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.

Authors:  Keith D Lindor; Kris V Kowdley; Velimir A C Luketic; M Edwyn Harrison; Timothy McCashland; Alex S Befeler; Denise Harnois; Roberta Jorgensen; Jan Petz; Jill Keach; Jody Mooney; Carol Sargeant; Julie Braaten; Tamara Bernard; Debra King; Ellen Miceli; Jeff Schmoll; Tanya Hoskin; Prabin Thapa; Felicity Enders
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

Review 9.  Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?

Authors:  Ulrich Beuers; Gerd A Kullak-Ublick; Thomas Pusl; Erik R Rauws; Christian Rust
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

10.  Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis.

Authors:  Sanjay Y Bangarulingam; Andrea A Gossard; Bret T Petersen; Beverly J Ott; Keith D Lindor
Journal:  Am J Gastroenterol       Date:  2009-03-03       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.